Abstract Guidelines
Abstract Submission Guidelines
ABSTRACT SUBMISSIONS ARE NOW OPEN
Late-breaker abstract submissions will open in February 2026.
To be eligible for consideration as a late-breaking abstract, the work described should be original research that has been completed after the regular abstract submission deadline. The content must be considered as urgent and significant in nature to be considered in this category. Priority will be given to clinical trial findings and research that is matched to the meeting themes. Abstracts that describe incomplete studies, literature reviews lacking practice guidance, or trial protocols will not be accepted.
Watch This MASCC Webinar!
Learn how to write an excellent abstract that will get your research noticed.
This webinar was hosted by the MASCC Awards Committee. The presenters will discuss why writing a compelling abstract is important, what elements to include, and how to avoid common pitfalls.
Click the links below to jump to a particular topic:
Abstract Authorship & Limitations
Other Information Required During Submission
Next Steps After Abstract Submission Deadline and Acceptance
Submission Process
All abstracts must be submitted via this website. When abstract submission opens, there will be a button below to click to submit an abstract. Refer to the deadline table here.
Note: The submission platform (Fourwaves) restricts all submitting authors from submitting more than TWO abstracts. However, the authorship limitation followed by MASCC is that you cannot be the MAIN AUTHOR on more than TWO abstracts. You may need to create/use a second login if you are assisting with the submission of more than two abstracts.
ALL ABSTRACTS MUST BE SUBMITTED IN ENGLISH.
The use of Artificial Inelegance (AI)
MASCC expects all submitted abstracts to represent the original intellectual and scientific work of the listed authors. Generative artificial intelligence (AI) tools (e.g., ChatGPT, Claude, Gemini) may not be used to generate the scientific content of an abstract, including the study rationale, methods, results, interpretation, or conclusions, nor to create, alter, or fabricate data, images, or references. Limited use of AI tools to improve spelling, grammar, or language clarity is permitted, provided the scientific content remains entirely the authors’ own. AI tools may not be listed as authors, as they cannot take responsibility or accountability for the work. Authors bear full responsibility for the accuracy and integrity of all submitted content. Undisclosed or prohibited use of AI may result in rejection of the abstract or withdrawal from the program.
Abstract Authorship & Limitations
- Authors may be the main author on a maximum of TWO abstracts.
- Authors may be the presenting author on a maximum of TWO abstracts.
- Authors may be a co-author on any number of abstracts.
- The submitter is required to ensure that all authors/co-authors are aware of the content of the abstract before submitting.
- The presenting author may be changed until the early bird registration deadline. Please email events@mascc.org to submit a change.
- The presenting author must attend in person to present (virtual options will not be available).
- All accepted abstracts must have at least ONE co-author (usually this is the presenting author) who is registered and who has paid the registration fees for the MASCC/ISOO 2027 Annual Meeting by the early bird deadline (Thursday, April 22, 2027) to be included in the scientific program and published in the journal Supportive Care in Cancer.
- All presenting authors of oral proffered papers must be registered and have paid the registration fees for the MASCC/ISOO 2027 Annual Meeting by the early bird deadline on Thursday, April 22, 2027.
- All presenting authors of oral rapid e-poster presentations must be registered and have paid the registration fees for the MASCC/ISOO 2027 Annual Meeting by June 3, 2027.
Abstract Structure
- All abstracts must be submitted and presented in clear ENGLISH with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility), or by a copy editor prior to submission.
- The abstract title is limited to 150 characters including spaces.
- The abstract title must be entered in UPPER CASE (e.g. “COMMON BLEEDING DISORDERS”).
- The abstract text is limited to 300 words total. The submission platform will show you a live word count at the bottom of the page, but it will not stop you from typing if you exceed the word limit. It is the responsibility of the submitting author to ensure that you do not exceed the word limit.
- The following structure must be followed when submitting an abstract:
- Introduction
- Methods
- Results
- Conclusions
- Each abstract can contain up to THREE images or tables. To include a table, you can prepare the table in another application and take a screenshot of the table to include it as an image in the submission. When preparing tables/images, please consider that the abstracts are published on letter size paper (8.5″ x 11″) with two columns. This may limit the ability to read your tables/images if they are too wide and need to be resized to fit this layout.
- Trials in progress are permitted. However, the acceptance of your abstract will be determined by the reviewers who will be evaluating your abstract in relation to other abstracts which include results. The review process is competitive. You may wish to delay your submission for when you have more information/results to present.
- Abstracts containing previously presented data are eligible for submission. However, inclusion of updated data is encouraged.
- If your abstract has been published in another journal, please consider any embargoes or limitations these publications may have. MASCC does not have any restrictions. However, we encourage you to update the title and content to avoid any copyright issues.
- Upon submission, the submitter confirms that the abstract has been proofread and that all information is correct.
- Upon submission, the submitter confirms that any patient photos and/or data have been released and approved by the patient for publication.
- Changes are not permitted after the submission deadline.
Other Information Required During Submission
- The following details are required for EACH co-author, including the submitting author:
- Full first and family name(s)
- Affiliations including the department, institution/hospital, city, state (if relevant), and country (e.g. “Department of Psychology, University of Lille, Lille, France”)
- Keywords for the abstract
- Abstract topic (see the list below)
- The preferred presentation type:
- E-poster (available to view during meeting)
- Oral rapid e-poster presentation (3 minutes rapid oral + 2 minutes Q&A, presented in the Exhibition Hall)
- Oral proffered paper (10 minutes oral presentation made during a parallel session)
- If you are applying for an award and/or scholarship, please ensure you also have the following information prepared:
- Your degree, including year commenced and year completed (or will be completed)
- Information about any funding available to you
- IMPORTANT: Abstracts applying for a Conference Scholarship are due before the regular deadline on Wednesday, December 16, 2026.
Abstract Topics
All abstracts must be relevant to supportive care in cancer. This year’s topics include:
- Antiemetics
- Cancer Pain
- Digital Health & New Technologies
- Disparities
- Emerging Toxicities
- Exercise Oncology
- Fatigue
- Geriatrics
- Hematological Toxicities
- Informal Caregivers
- Lifestyle & Integrative Medicine
- Mucositis
- Multidisciplinary Care
- Neurological Complications
- Nutrition & Cachexia
- Oncodermatology
- Oral Care
- Organ-based Toxoicities
- Palliative Care
- Pediatrics
- Policy-making in Supportive Care
- Precision Medicine
- Psychosocial
- Survivorship
- Workforce: Adapting to AI and Digital Innovation
- Other
Abstract Review Guidelines
Abstracts will be reviewed with four major criteria in mind:
- Impact – Significance of the science in improving care
- Innovation – Novelty
- Approach – Study design, sample size, rigidity of research
- Presentation – Clarity, logic, completeness of data presented
Late-breaker abstracts will also be evaluated on meeting the “late-breaker” criteria: Original research that is not completed until after the regular submission deadline. The content must meet criteria for urgency and significant scientific importance to be considered in this category.
Keeping these above domains in mind, each abstract will be ranked against each other within the same topic for acceptance as an e-poster only, oral rapid e-poster, oral proffered paper, or rejected.
Next Steps After Abstract Submission Deadline and Acceptance
- The MASCC/ISOO 2027 Scientific Committee will determine acceptance for presentation at the Annual Meeting.
- All notifications regarding abstract status, including notifications regarding abstract submission, abstract acceptance and scheduling, will be sent to the submitter. The submitter will be responsible for informing the other authors/co-authors about the status of the abstract.
- Accepted abstracts and scholarship/award recipients will be notified by email to the main author.
- All accepted abstracts must have at least ONE co-author (usually this is the presenting author) who is registered and who has paid the registration fees to attend the MASCC/ISOO 2027 Annual Meeting by the early bird deadline (Thursday, April 22, 2027) to be included in the scientific program and published in the journal Supportive Care in Cancer.
- All presenting authors of oral proffered papers must be registered and have paid the registration fees for the MASCC/ISOO 2027 Annual Meeting by the early bird deadline on Thursday, April 22, 2027.
- All presenting authors of oral rapid e-poster presentations must be registered and have paid the registration fees for the MASCC/ISOO 2026 Annual Meeting by June 3, 2027.
- All presenting authors must attend in-person to present (virtual options will not be available).
- All presenting authors are required to prepare for presentation(s) and consult the speaker guidelines.
- Oral rapid e-posters must be uploaded in .pdf format to the e-poster platform by the date provided.
- Oral proffered paper powerpoint presentation decks must be delivered in-person to the Speaker Ready Room on a USB drive at the meeting venue a minimum of TWO hours before the assigned session time (this may mean the day prior for early morning sessions).